Clinical Trials

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT05966194 2024-11-15

KEVLARx

Phase 2 Recruiting

216 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03515538 2024-11-04

PREVLAR

53 enrolled 15 charts

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03972527 2024-08-21

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Phase NA Completed

85 enrolled

Head and Neck Neoplasms, Stomatitis, Ulcer

NCT05994638 2023-10-13

Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy

Phase NA Unknown

10 enrolled

Deglutition Disorders, Head and Neck Neoplasms, Stomatitis

NCT04648020 2023-05-31

VOICE

Phase 2/3 Terminated

190 enrolled

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Stomatitis, Oral Ulcer, Mucositis

NCT05055726 2022-11-16

BOOM

Phase 4 Completed

100 enrolled

Head and Neck Neoplasms, Stomatitis

NCT03237325 2022-11-08

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

266 enrolled 11 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis

NCT04699487 2022-10-10

PrOMiSE

Phase NA Completed

15 enrolled

Head and Neck Neoplasms, Stomatitis, Ulcer

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

38 enrolled 10 charts

Head and Neck Neoplasms, Stomatitis

NCT02399228 2021-11-19

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis

13 enrolled 10 charts

Head and Neck Neoplasms, Stomatitis

NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Phase 2 Terminated

76 enrolled 25 charts

Head and Neck Neoplasms, Stomatitis

NCT03988556 2021-04-30

SafePBM

Phase NA Completed

72 enrolled

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Radiodermatitis, Stomatitis

NCT02324335 2019-01-16

Brilacidin

61 enrolled 12 charts

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT01400620 2018-03-13

Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer

110 enrolled

Head and Neck Neoplasms, Stomatitis

NCT02630004 2018-03-01

MUCOMEL

Phase 1/2 Completed

84 enrolled

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT00131638 2016-12-16

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer

241 enrolled

Head and Neck Neoplasms, Neoplasms, Stomatitis

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

188 enrolled 19 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

NCT01921426 2016-09-22

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Phase 1 Completed

30 enrolled

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Phase 3 Terminated

240 enrolled

Head and Neck Neoplasms, Stomatitis

NCT01283906 2013-09-12

MuGard

Phase 4 Completed

120 enrolled

Head and Neck Neoplasms, Stomatitis, Neoplasms, Squamous Cell, Mucositis

NCT00790322 2010-02-19

Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

130 enrolled

Head and Neck Neoplasms, Neoplasms, Stomatitis

NCT00540332 2009-03-02

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Phase 1/2 Withdrawn

Head and Neck Neoplasms, Neoplasms, Stomatitis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

110 enrolled